X4 Pharmaceuticals, Inc.XFORNASDAQ
LOADING
|||
Trailing Twelve Months (TTM) Metrics
Per Share (TTM)
Revenue/Share$4.58
Net Income/Share$-12.83
Operating CF/Share$-13.91
Free CF/Share$-14.32
Cash/Share$16.51
Book Value/Share$8.31
Tangible Book/Share$4.70
Equity/Share$8.31
Interest Debt/Share$11.65
CapEx/Share$0.41
Dividend/Share$0.00
Valuation
Market Cap$44.37M
Enterprise Value$51.87M
P/E Ratio-0.30P/S Ratio1.31P/OCF Ratio-0.28
P/FCF Ratio-0.42
P/B Ratio0.47P/TB Ratio0.47
EV/Sales1.53EV/EBITDA-0.61
Graham Valuation
Graham Number--
Graham Net-Net$3.20
Profitability
Earnings Yield-329.86%FCF Yield-239.20%ROE-343.67%ROIC-70.02%Return on Tangible Assets-69.53%Dividend
Dividend Yield0.00%Payout Ratio0.00%Capital Allocation
CapEx/OCF-2.95%
CapEx/Revenue8.95%
CapEx/Depreciation2.29
SBC/Revenue12.49%
SG&A/Revenue0.00%
R&D/Revenue223.39%
Liquidity & Solvency
Debt/Equity1.26Debt/Assets0.47Debt/Market Cap1.74
Net Debt/EBITDA-0.09
Current Ratio5.65Interest Coverage-11.00xIncome Quality1.08Efficiency
Days Sales Outstanding17 days
Days Payables Outstanding324 days
Days Inventory261 days
Receivables Turnover21.16x
Payables Turnover1.13x
Inventory Turnover1.40x
Capital Structure
Tangible Assets$34.83M
Working Capital$109.30M
Invested Capital$138.08M
Intangibles/Assets16.38%